GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022

by GeneOnline
Share To
As part of the U.S. Food and Drug Administration (FDA), the Center for Drug Evaluation and Research (CDER) grants approval to new drugs or biologics in a variety of therapeutic areas every year. These products contain ingredients that have not been previously approved by the FDA and are important new therapies for patient populations in their respective areas.

By December 30, 2022, 37 drugs were approved by the FDA, covering a wide range of diseases including cancer, diabetes, blood disorders, autoimmune diseases, infections, and rare diseases. The following is a compilation of the top 10 FDA-approved drugs and biologics in various therapy areas selected by GeneOnline, with a review of key clinical data and mechanism of action (MOA), hoping to help readers to predict the development trend in 2023 by looking at novel drug approvals for 2022.

It's free! Log in now to read

Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
Assessment of Supply Chain Risk Key to Improving Medicine Access
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
Autoimmune Patients See Breakthrough Response to Allogeneic CD19-Targeted CAR-T Therapy
Rising Bird Flu Cases in Cattle and Humans Drive Global Efforts in Vaccination, Genetic Monitoring, and Surveillance
Scroll to Top